StockData
Vivani Medical, Inc. logo

Vivani Medical, Inc. (VANI) stock

VANINasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.14+0.05 (+4.59%)

Close on Nov 20, 2026Market cap $102.83MP/E –Yield –

Vivani Medical free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Vivani Medical's free cash flow for the twelve months ending Jun 30, 2026 was -$26.50M. For fiscal 2025 it was -$25.49M. The highest annual figure on record is -$11.52M in fiscal 2021.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$25.49M–
FY2024Dec 31, 2024-$21.34M–
FY2023Dec 31, 2023-$24.59M–
FY2022Dec 31, 2022-$19.13M–
FY2021Dec 31, 2021-$11.52M–
FY2020Dec 31, 2020-$17.15M–
FY2019Dec 31, 2019-$28.12M–
FY2018Dec 31, 2018-$29.97M–
FY2017Dec 31, 2017-$24.21M–
FY2016Dec 31, 2016-$25.56M–
FY2015Dec 31, 2015-$21.31M–
FY2014Dec 31, 2014-$17.65M–
FY2013Dec 31, 2013-$17.67M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$6.13M–
Q1 FY2026Mar 31, 2026-$6.20M–
Q4 FY2025Dec 31, 2025-$6.99M–
Q3 FY2025Sep 30, 2025-$7.17M–
Q2 FY2025Jun 30, 2025-$6.16M–
Q1 FY2025Mar 31, 2025-$5.17M–
Q4 FY2024Dec 31, 2024-$6.11M–
Q3 FY2024Sep 30, 2024-$5.70M–
Q2 FY2024Jun 30, 2024-$4.84M–
Q1 FY2024Mar 31, 2024-$4.69M–
Q4 FY2023Dec 31, 2023-$4.22M–
Q3 FY2023Sep 30, 2023-$7.77M–
Q2 FY2023Jun 30, 2023-$5.59M–
Q1 FY2023Mar 31, 2023-$7.00M–
Q4 FY2022Dec 31, 2022-$5.29M–
Q3 FY2022Sep 30, 2022-$7.09M–
Q2 FY2022Jun 30, 2022-$3.54M–
Q1 FY2022Mar 31, 2022-$3.21M–
Q4 FY2021Dec 31, 2021-$3.22M–
Q4 FY2020Dec 31, 2020-$1.45M–
Q3 FY2020Sep 30, 2020-$1.48M–
Q2 FY2020Jun 30, 2020-$5.24M–
Q1 FY2020Mar 31, 2020-$8.99M–
Q4 FY2019Dec 31, 2019-$7.49M–
Q3 FY2019Sep 30, 2019-$6.69M–
Q2 FY2019Jun 30, 2019-$6.76M–
Q1 FY2019Mar 31, 2019-$7.19M–
Q4 FY2018Dec 31, 2018-$7.75M–
Q3 FY2018Sep 30, 2018-$7.48M–
Q2 FY2018Jun 30, 2018-$7.89M–
Q1 FY2018Mar 31, 2018-$6.85M–
Q4 FY2017Dec 31, 2017-$6.80M–
Q3 FY2017Sep 30, 2017-$4.71M–
Q2 FY2017Jun 30, 2017-$6.02M–
Q1 FY2017Mar 31, 2017-$6.69M–
Q4 FY2016Dec 31, 2016-$7.10M–
Q3 FY2016Sep 30, 2016-$6.06M–

More Vivani Medical figures

See a number that looks wrong?